Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results
LEXINGTON, Mass.–(BUSINESS WIRE)–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2021.
Our development priority is to advance CTP-543 through its pivotal trials for alopecia areata in support of…
